The ADDICT-pedGLIO (NCT04911621) trial is an ongoing investigation into a promising evolution of DC vaccinations utilizing Wilms’ tumor 1 (WT1) mRNA, an antigen overexpressed in pHGG including DIPG. Here, WT1 is linked to diffuse intrinsic pontine glioma.